News
Although the mother and her breastmilk tested positive for CAR T cells, the baby did not, showing only normal T- and B-cell subsets. The first known case of healthy pregnancy and birth by a woman with ...
Though the exact mechanism of action is unclear, it is believed that in patients with Prader-Willi syndrome ... and food-related behaviors. Findings showed a statistically significant worsening ...
Get Instant Summarized Text (Gist) The Ottoman Empire's apparent religious tolerance was a mechanism for control, involving population surveillance and internal passports. Non-Muslim religious ...
This medication is now the first and only approved treatment for cholestatic pruritus associated with Alagille syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC) in Japan. The ...
Rachel Reeves has denied her own government's findings that her welfare reforms will push 250,000 people into poverty while refusing to rule out further cuts. The chancellor wants to save £5 ...
It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the U.S. three months of age and older and in Europe for patients two months of age and older.
LIVMARLI is the first and only treatment available for cholestatic pruritus in patients with Alagille syndrome and Progressive Familial Intrahepatic Cholestasis in Japan Mirum Pharmaceuticals ...
March 27, 2025 – The FDA has approved a drug to treat a key symptom of a rare life-threatening genetic disorder known as Prader-Willi syndrome (PWS) in adults and children ages 4 or older.
for the treatment of hyperphagia in adults and children 4 years of age and older with Prader-Willi syndrome (PWS). Soleno expects VYKAT XR to be available in the U.S. beginning in April 2025.
Antidepressant discontinuation syndrome (ADS), or antidepressant withdrawal, includes all the symptoms people might experience when they stop taking their antidepressants, such as nausea ...
There is a simple discount patient access scheme for fenfluramine. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...
The findings suggest the presence of vertical shafts, spiral staircases, and massive chambers. Skeptics question the validity of these claims, but further high-resolution imaging is planned to confirm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results